Latest Remuneration News

Page 9 of 79
Neurizon Therapeutics announces the resignation of CEO Dr Michael Thurn, with Executive Chair Sergio Duchini stepping in temporarily as the company embarks on a global hunt for new leadership.
Ada Torres
Ada Torres
16 Mar 2026
Humm Group has appointed CEO Angelo Demasi as Managing Director, reinforcing governance and leadership alignment amid ongoing transformation efforts.
Claire Turing
Claire Turing
13 Mar 2026
Energy World Corporation appoints Alan Jowell as Executive Chairman to spearhead its strategic review and project development, while exploring asset sales alongside its flagship Pagbilao LNG and Power Project.
Maxwell Dee
Maxwell Dee
9 Mar 2026
Belararox Limited has appointed Will Dix as CEO, bringing deep mining expertise to lead its copper-focused projects in Argentina and Botswana. The company also promotes Christian Blaser to oversee exploration activities across both regions.
Maxwell Dee
Maxwell Dee
5 Mar 2026
Cluey Ltd announces significant leadership changes including the retirement of a long-serving director and a CEO stepping down, while affirming continuity in its strategic direction.
Victor Sage
Victor Sage
5 Mar 2026
Kalamazoo Resources has appointed mining veteran Andrew McDougall as CEO to lead its flagship Ashburton Gold Project through critical feasibility stages and drive broader portfolio growth.
Maxwell Dee
Maxwell Dee
5 Mar 2026
Straker Ltd announces a pivotal leadership shift with the appointment of David Sowerby and Indiver Nagpal as Co-CEOs, marking a new era focused on commercial expansion and AI innovation. Founder Grant Straker transitions to a strategic board role to steer the company’s AI future.
Sophie Babbage
Sophie Babbage
4 Mar 2026
Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.
Eva Park
Eva Park
3 Mar 2026
Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.
Claire Turing
Claire Turing
27 Feb 2026
Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.
Ada Torres
Ada Torres
27 Feb 2026
Brisbane Broncos Limited has reported a robust 2025 financial year, with profit before tax soaring 35% to $11.34 million, buoyed by premiership wins in both the NRL and NRLW competitions. The club also declared a special dividend, reflecting its strong commercial and community momentum.
Victor Sage
Victor Sage
27 Feb 2026
PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.
Ada Torres
Ada Torres
27 Feb 2026